HISTAMINERGIC ACTIVATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS

被引:54
|
作者
KJAER, A [1 ]
LARSEN, PJ [1 ]
KNIGGE, U [1 ]
WARBERG, J [1 ]
机构
[1] UNIV COPENHAGEN, PANUM INST, DEPT MED ANAT, DK-2200 COPENHAGEN, DENMARK
关键词
D O I
10.1210/en.135.3.1171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Centrally administered histamine (HA) stimulates the secretion of adenohypophysial POMC-derived peptides, which subsequently cause release of corticosterone. The effect of HA on POMC-derived peptide release is indirect, and it is possible that hypothalamic neurons containing corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), or oxytocin (OT) are involved in the mediation of this response. We studied the effect of HA on: 1) expression of CRH, AVP, and OT messenger RNA (mRNA) at the hypothalamic level; 2) expression of c-fos and POMC mRNA at the pituitary level; and 3) peripheral plasma levels of AVP, OT, ACTH, beta-endorphin (beta-END), and corticosterone. HA (270 nmol) infused intracerebroventricularly increased the expression of CRH, AVP, and OT mRNA in the paraventricular nucleus as well as that of OT mRNA in the supraoptic nucleus of the hypothalamus. At the pituitary level the expression of mRNA for c-fos and POMC increased in the anterior but not in the intermediate lobe in response to HA. Plasma levels of AVP, OT, ACTH, beta-END, and corticosterone all increased in response to central HA administration. Circulating levels of AVP and OT peaked after 5 min, ACTH and beta-END after 15 min, whereas corticosterone levels were highest after 30 min. In concert with our earlier discoveries, the present data support the hypothesis that HA-induced secretion of ACTH and beta-END is mediated via central activation of hypothalamic neuroendocrine neurons containing CRH, AVP, and/or OT.
引用
收藏
页码:1171 / 1177
页数:7
相关论文
共 50 条
  • [1] HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    HONOUR, JW
    RESPIRATORY MEDICINE, 1994, 88 : 9 - 15
  • [2] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    FEEK, CM
    MARANTE, DJ
    EDWARDS, CRW
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1983, 12 (03): : 597 - 618
  • [3] Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary-adrenal axis
    Bugajski, AJ
    Koprowska, B
    Thor, P
    Glód, R
    Bugajski, J
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (04): : 907 - 915
  • [4] Hypothalamic-pituitary-adrenal axis in schizophrenia
    Altamura, AC
    BIOLOGICAL PSYCHIATRY, 1996, 40 (06) : 560 - 561
  • [5] Medicines of the hypothalamic-pituitary-adrenal axis
    Reyt, Vincent
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2018, 57 (574): : 19 - 21
  • [6] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN DEPRESSION
    MELTZER, HY
    LOWY, MT
    KOENIG, JI
    ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1987, 43 : 165 - 182
  • [7] TESTING HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1970, 1 (5697): : 644 - +
  • [8] Neural basis for fasting activation of the hypothalamic-pituitary-adrenal axis
    Douglass, Amelia M.
    Resch, Jon M.
    Madara, Joseph C.
    Kucukdereli, Hakan
    Yizhar, Ofer
    Grama, Abhinav
    Yamagata, Masahito
    Yang, Zongfang
    Lowell, Bradford B.
    NATURE, 2023, 620 (7972) : 154 - +
  • [9] Significance of the hypothalamic-pituitary-adrenal axis
    Bullmann, C.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2020, 18 (03): : 135 - 139
  • [10] THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN OBESITY
    CHALEW, S
    NAGEL, H
    SHORE, S
    OBESITY RESEARCH, 1995, 3 (04): : 371 - 382